This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Ludwig-Maximilians-Universitat München, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stuttgart, DE (2018)
- Stuffgart, DE (2019)
Company Filing History:
2 out of 50 
2 out of 1,334 
Years Active: 2018-2019
Title: Thomas Hirschberger: Innovator in Neurodegenerative Disease Research
Introduction
Thomas Hirschberger is an inventor based in Stuttgart, Germany. He has made significant contributions to the field of neurodegenerative diseases through his research and innovative ideas. Although he currently holds no granted patents, his work is focused on developing new therapeutic approaches.
Latest Patent Applications
Hirschberger's notable patent application is titled "New Drug for Inhibiting Aggregation of Proteins Involved in Diseases Linked to Protein Aggregation and/or Neurodegenerative Diseases." This invention relates to a compound represented by formula (E) for use in the treatment or prevention of diseases associated with protein aggregation and neurodegenerative conditions. The application also discusses pharmaceutical and diagnostic compositions that include the compound, as well as methods for imaging deposits of aggregated proteins. The formula (E) includes various components that can be selected from specific chemical structures.
Conclusion
Thomas Hirschberger is an emerging inventor whose research focuses on innovative solutions for neurodegenerative diseases. His work has the potential to contribute significantly to the medical field, particularly in the treatment of conditions linked to protein aggregation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile